Immune Indicator Model for Predicting Efficacy of PD-1 Monoclonal Antibody

Clinical trial NCT05392413 · RECRUITING

Trial details

NCT number: NCT05392413
Sponsor: Nanfang Hospital, Southern Medical University
Status: RECRUITING
Study type: OBSERVATIONAL

Esophageal Squamous Cell Carcinoma PD-1 Inhibitor

Start date: 2022-08-01
Primary completion: 2025-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.